Bio-G engineering teams have successfully modeled more than 30% of the world’s biomanufacturing capacity. Our software toolsets and expertise in capacity engineering, scheduling, data integration, and facility fit provide a high level of return on project investment and enable our client’s facilities to run faster, produce more product, and operate more efficiently.

Our clients include developmental companies producing their first small batches or outsourcing production to a contract manufacturer, to the largest, most technologically advanced, multi-national corporations. These companies have a wide variety of processes including fed batch, perfusion, and fill/finish and they produce monoclonal antibodies, enzymes, API’s, vaccines and other products that address the world’s most critical medical needs.

Bio-G is trusted world-wide to solve the most difficult biomanufacturing challenges in debottlenecking, scheduling, utilities, labor and waste analysis, resource optimization and other critical areas.